DivestmentAug 4, 2026, 07:12 AM
AdaptHealth Divests Diabetes Health for $235M; Q2 Net Loss $145.3M
AI Summary
AdaptHealth Corp. announced its second quarter 2026 financial results, reporting a net loss of $145.3 million, largely due to a $144.2 million goodwill impairment. The company also disclosed a definitive agreement to sell its Diabetes Health business for $235.0 million, a key step in focusing its portfolio. Net revenue grew 12.7% to $740.3 million, but Adjusted EBITDA declined 3.2% to $132.0 million. AdaptHealth revised its full-year 2026 financial guidance downwards, citing the divestment and operational impacts.
Key Highlights
- Entered definitive agreement to sell Diabetes Health business for $235.0 million cash.
- Reported Q2 net loss of $145.3 million, primarily due to a $144.2 million goodwill impairment.
- Net revenue for Q2 increased 12.7% to $740.3 million.
- Adjusted EBITDA for Q2 decreased 3.2% to $132.0 million.
- Revised FY2026 Net Revenue guidance to $2.85 billion to $2.89 billion.
- Revised FY2026 Adjusted EBITDA guidance to $490 million to $520 million.
- Completed workforce restructuring, expecting $19 million in annualized savings.
Price Impact
More from AHCO